Vital Clinical Insights and Analytics

for Experts from Experts

Arlington Medical Resources (AMR) is the premier provider of medical data from hospitals and other health care facilities throughout the United States, Europe and Asia. Learn More

AREAS OF EXPERTISE

Hospital Therapeutic Audits

AMR provides comprehensive audits of clinical patient data in different therapeutic areas like Anti-infectives, Cardiovascular products, Plasma Expanders and Immunoglobulin products in the hospital setting ...
Learn More

Diagnostic Imaging

AMR produces the Imaging Market Guide, a syndicated audit of diagnostic imaging procedure volumes and contrast media usage. The audit covers conventional x-ray, CT scanning, MRI, ultrasound, nuclear medicine and cardiac cath lab procedure volumes, with iodinated contrast agent and radiopharmaceutical usage information in hospital and non-hospital settings ...
Learn More

Hospital Market Research Updates

Register below to receive our monthly update.
First Name:
Last Name:
Title:
Company:
Email:

  I have read and agree to abide by the Arlington Medical Resources Terms of Use and Privacy Policy.

Click here to read our latest issue.

Studies in Development

Hospital Formulary Insights
Through a survey of hospital pharmacy directors and clinicians that sit on their hospital's P&T committee, we are able to understand the influence of cost factors, clinical factors, and product attributes on formulary decisions.

LaunchTrends®: Teflaro
This series of three post-launch studies evaluate the trial and usage of Teflaro for the treatment of bacterial infections. Through surveys with hospital-based infectious disease specialists and internists, we track the trial, adoption and usage of Teflaro from launch through one-year post launch.

LaunchTrends®: Dificid
This series of one pre-launch and three post-launch studies evaluate the trial and usage of Dificid for the treatment of Clostridium difficile infection. Through surveys with hospital-based infectious disease specialists, geriatricians and internists, we track the awareness, trial, adoption and usage of Dificid from pre-launch through one-year post launch.

Latest Press Releases [ view all ]

Featured Studies

  • Hospital Insight Series: Nosocomial Pneumonia
    Nosocomial pneumonia is an important segment of the hospital antibiotics market because of the high morbidity and mortality of this infection, limited treatment options, and the increasing incidence of multidrug-resistant pathogens ...
  • Hospital Insight Series: Hospital Anti-Infectives
    The hospital anti-infectives market is a high-value segment of the overall antibacterial market, due, in part, to a variety of unmet needs, the increasing prevalence of drug-resistant pathogens, and the routine use ...
  • Hospital Insight Series: Clostridium Difficile Infections
    With limited therapeutic options available and increasing reports of treatment failures, interviewed thought leaders and physicians alike highlight the need for new, more-effective CDI therapies
Take survey
 © 2009-2012 AMR/Arlington Medical Resources, Inc. All rights reserved.
Decision Resources Group brands include: